Moineau-Vallée, K.; Rinfret, J.; Luu Hoai, M.H.; St-Louis, V.; Berthelet, F.; Létourneau-Guillon, L.; Lemieux-Blanchard, É.; Prat, A.; Adam, J.-P.
Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant. Curr. Oncol. 2021, 28, 203-208.
https://doi.org/10.3390/curroncol28010022
AMA Style
Moineau-Vallée K, Rinfret J, Luu Hoai MH, St-Louis V, Berthelet F, Létourneau-Guillon L, Lemieux-Blanchard É, Prat A, Adam J-P.
Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant. Current Oncology. 2021; 28(1):203-208.
https://doi.org/10.3390/curroncol28010022
Chicago/Turabian Style
Moineau-Vallée, Karine, Justine Rinfret, My Hanh Luu Hoai, Valérie St-Louis, France Berthelet, Laurent Létourneau-Guillon, Émilie Lemieux-Blanchard, Alexandre Prat, and Jean-Philippe Adam.
2021. "Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant" Current Oncology 28, no. 1: 203-208.
https://doi.org/10.3390/curroncol28010022
APA Style
Moineau-Vallée, K., Rinfret, J., Luu Hoai, M. H., St-Louis, V., Berthelet, F., Létourneau-Guillon, L., Lemieux-Blanchard, É., Prat, A., & Adam, J.-P.
(2021). Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant. Current Oncology, 28(1), 203-208.
https://doi.org/10.3390/curroncol28010022